Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 1
2010 1
2015 1
2016 1
2019 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Current management of advanced and metastatic renal cell carcinoma.
Ather MH, Masood N, Siddiqui T. Ather MH, et al. Urol J. 2010 Winter;7(1):1-9. Urol J. 2010. PMID: 20209445 Free article. Review.
INTRODUCTION: Unresectable renal cell carcinoma (RCC) is a technically incurable condition. ...Systemic therapeutic agents are showing promising results....
INTRODUCTION: Unresectable renal cell carcinoma (RCC) is a technically incurable condition. ...Systemic thera …
Targeted therapies in the treatment of advanced renal cell carcinoma.
Seront E, Machiels JP. Seront E, et al. Recent Pat Anticancer Drug Discov. 2009 Jun;4(2):146-56. doi: 10.2174/157489209788452803. Recent Pat Anticancer Drug Discov. 2009. PMID: 19519537 Review.
Renal cell carcinoma (RCC) represents five percent of adult epithelial cancers and clear cell RCC is the most frequent histological subtype. ...This paper provides a comprehensive review of the new targeted therapies currently available in clini …
Renal cell carcinoma (RCC) represents five percent of adult epithelial cancers and clear cell RCC is the most fr …
Efficacy and safety of HDACIs in the treatment of metastatic or unresectable renal cell carcinoma with a clear cell phenotype: A systematic review and meta-analysis.
Chen J, Ren JJ, Cai J, Wang X. Chen J, et al. Medicine (Baltimore). 2021 Aug 6;100(31):e26788. doi: 10.1097/MD.0000000000026788. Medicine (Baltimore). 2021. PMID: 34397830 Free PMC article.
BACKGROUND: In this study, we evaluated the efficacy and safety of histone deacetylase inhibitors (HDACIs) in the treatment of renal cell carcinoma (RCC). METHODS: PubMed, EMBASE, the Cochrane Library, CNKI, and the Wanfang database were searched to retrieve …
BACKGROUND: In this study, we evaluated the efficacy and safety of histone deacetylase inhibitors (HDACIs) in the treatment of renal …
C-arm CT-guided renal arterial embolisation followed by radiofrequency ablation for treatment of patients with unresectable renal cell carcinoma.
Duan XH, Li YS, Han XW, Wang YL, Jiao DC, Li TF, Chen PF, Fang Y. Duan XH, et al. Clin Radiol. 2016 Jan;71(1):79-85. doi: 10.1016/j.crad.2015.10.012. Epub 2015 Nov 18. Clin Radiol. 2016. PMID: 26602936
AIM: To explore the value of using flat detector (FD) equipped angiographic C-arm CT (CACT) systems in treating unresectable renal cell carcinoma (RCC) by selective renal arterial embolisation (RAE) followed by radiofrequency ablation (RFA) (RAE …
AIM: To explore the value of using flat detector (FD) equipped angiographic C-arm CT (CACT) systems in treating unresectable renal …
A prospective, open-label, interventional study protocol to evaluate treatment efficacy of nivolumab based on serum-soluble PD-L1 concentration for patients with metastatic and unresectable renal cell carcinoma.
Bando Y, Hinata N, Omori T, Fujisawa M. Bando Y, et al. BMJ Open. 2019 Dec 10;9(12):e030522. doi: 10.1136/bmjopen-2019-030522. BMJ Open. 2019. PMID: 31826889 Free PMC article.
INTRODUCTION: Nivolumab has been proven to prolong overall survival as a second-line therapy for patients with advanced renal cell carcinoma (RCC) in a phase III clinical trial. ...For this prospective study, statistical power calculation indicated tha …
INTRODUCTION: Nivolumab has been proven to prolong overall survival as a second-line therapy for patients with advanced renal …
Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: initial experience.
Yamakado K, Nakatsuka A, Kobayashi S, Akeboshi M, Takaki H, Kariya Z, Kinbara H, Arima K, Yanagawa M, Hori Y, Kato H, Sugimura Y, Takeda K. Yamakado K, et al. Cardiovasc Intervent Radiol. 2006 May-Jun;29(3):389-94. doi: 10.1007/s00270-004-0090-9. Cardiovasc Intervent Radiol. 2006. PMID: 16502180
The purpose of the study was to evaluate the feasibility, safety, and therapeutic effects of the combination of renal arterial embolization and radiofrequency (RF) ablation to reinforce the anticancer effect on renal cell carcinomas (RCCs) measuring 3. …
The purpose of the study was to evaluate the feasibility, safety, and therapeutic effects of the combination of renal arterial …